effective diagnostic biomarkers and therapeutic targets for GC and thus provide patients with potentially better outcomes. 5, 6 Long noncoding RNA (lncRNA) is a class of RNAs of 200 nucleotides in length without a protein-coding ability. Sequencing technologies have shown that only ˂2% of transcripts transcribed from the human genome code for proteins, 7, 8 leaving much of the noncoding transcripts unexplored. Recent studies have revealed that lncRNAs are associated with GC tumorigenesis and metastasis, and have the potential to serve as diagnostic and prognostic biomarkers. 9, 10 For example, our previous study established a novel five plasma lncRNAbased panel [terminal differentiation-induced noncoding RNA (TINCR), CCAT2, AOC4P, BRAF-activated noncoding RNA (BANCR) and LINC00857] that discriminates GC from precancerous individuals with relatively high accuracy compared with widely used serum carcinoembryonic antigen, CA19-9, and CA125. 11 However, the molecular mechanism of these lncRNAs in GC initiation and development need to be clarified further.
In the present study, we investigated the clinical relevance and biological role of AOC4P in GC, as the role of TINCR, CCAT2, BANCR and LINC00857 in GC has been previously reported.
Methods
Tissue specimens GC tissues and adjacent normal tissues were collected from 63 patients who underwent surgery between January 2013 and December 2013 at the Department of General Surgery, Chinese PLA General Hospital. All patients were diagnosed by pathology. None of the patients had received preoperative chemotherapy or radiochemotherapy. Patient characteristics were obtained, including age, sex, T stage, lymph node status, tumor size, tumor differentiation, and TNM (tumor-nodemetastasis) stage according to the 7th edition American Joint Committee on Cancer Staging manual. Patients were followed up every 6 months. Patients with suspicion of recurrence were assessed by computed tomography. The last follow-up time was May 2017. Disease-free survival and overall survival times were calculated. All patients provided written informed consent about their tumor specimen for research use. The collection and use of patient's specimen was approved by the Ethics Committee of the Chinese PLA General Hospital (NO.S2016-057-01).
Cell lines and culture
Human GC cell lines MGC-803 and BGC-823 were purchased from the Chinese Academy of Sciences Committee on Type Culture Collection cell bank (Shanghai, China). The immortalized human gastric epithelial cell line GES-1 was obtained from the Institute of General Surgery at the Chinese PLA General Hospital. The cell lines were cultured as described previously. 11 RNA extraction and quantitative real-time polymerase chain reaction RNA was extracted from tissues and cultured cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's protocol. RNA concentrations and purity were measured by a NanoDrop 2000/2000c spectrophotometer (Thermo Fisher Scientific, Wilmington, USA). cDNA was synthesized from 3 μg extracted RNA using a reverse transcription kit (Invitrogen). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed as described previously. 11 Primer sequences are shown in the supplementary files.
Western blot assay
Western blot assays were performed as described previously. 12 In brief, extracted proteins from tissues and cell lines were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and then transferred to polyvinylidene fluoride membranes (Bio-Rad Laboratories, USA). After blocking, the membranes were incubated with a primary antibody overnight at 4°C. Then, the blotted membranes were incubated with a horseradish peroxidase-conjugated secondary antibody (1:2000) for 2 h at room temperature. Labeled proteins were detected using enhanced chemiluminescence following the manufacturer's protocol. β-Actin (1:1000, Cell Signaling, USA) was used as an internal control. Antibodies against the following proteins were used: E-cadherin (1:1000, Cell Signaling), matrix metalloproteinase-9 (MMP-9; 1:1000, Abcam, USA), vimentin (1:1000, Cell Signaling), cleaved caspase-3 (1:1000, Cell Signaling) and journals.sagepub.com/home/tag 3 cleaved poly (ADP-ribose) polymerase (PARP; 1:1000, Cell Signaling).
Immunohistochemistry
Immunohistochemistry (IHC) was performed using a standard technique with an avidin-biotinylated peroxidase complex as described previously. 12, 13 Sections were incubated with an anti-Ki-67 antibody (1:400, Cell Signaling) at 4°C overnight. Diaminobenzidine (DAKO, China) staining was used to detect immunoreactivity. The intensity of immunoreactivity was graded as 0, 1+, 2+, and 3+ for no staining, weak, medium, and strong staining, respectively. Scores of 0 and 1+ were regarded as low expression, while scores of 2+ and 3+ were considered as high expression. The proliferation index of the cancer cells = high expression cells/total cells × 100%.
Immunofluorescence staining
The 5 μm-thick, formalin-fixed, paraffin-embedded tissue sections were incubated with a primary antibody at 4°C overnight. Then, the sections were rinsed three times for 5 min each with phosphate-buffered saline (PBS) followed by incubation with Alexa Fluor-conjugated secondary antibodies at room temperature for 1 h. Fluorescence imaging was performed using a laser scanning confocal microscope (Fluoview FV1000, Olympus, Japan). Fluorescence staining was quantified using Tissue-Quest software (TissueGnostics GmbH). Tumor tissues were classified as high or low expression using a cutoff of the mean expression level of proteins (high expression ⩾ mean; low expression < mean). Antibodies against the following proteins were used: E-cadherin (1:100, Cell Signaling), MMP-9 (1:500, Abcam), and vimentin (1:100, Cell Signaling).
Colony formation assay
A total of 500 cells per well were seeded in a six-well plate in triplicate and maintained in a humidified atmosphere containing 5% CO 2 at 37°C. After culture for 10-14 days, cell colonies were washed with PBS, fixed with 4% paraformaldehyde for 30 min, and stained with a 0.1% crystal violet solution for 20 min. Colonies containing more than 50 cells were counted. 
Proliferation assay

Cell migration and invasion assays
Cell migration was measured using a Transwell chamber with an 8 μm pore size membrane according to the manufacturer's instructions. In brief, 3 × 10 5 cells in 200 μl serum-free medium were added to the upper chamber. For the invasion assay, 5 × 10 5 cells in 200 μl serum-free medium were added to the upper chamber coated with 1 mg/ml Matrigel. Subsequently, 500 μl serum-containing medium was added to the lower chamber. Cells were incubated at 37°C for 24 h, and then cells on the upper surface of the membrane were scraped off with cotton swabs. Cells that had migrated and invaded to the lower surface of the membrane were fixed and stained with a 0.1% crystal violet solution. Four random microscopic fields of the membrane were photographed, and cells were counted for statistical analysis.
Wound healing assay A total of 5 × 10 5 cells per well were seeded in six-well plates and cultured until 90% confluence. A 200 μl sterile pipette tip was used to make a straight scratch on the culture surface. Detached cells were washed off gently, and images of the scratch were photographed as a baseline. The medium was then replaced, and images of the same location were obtained under a microscope after 48 h. The healing rate was calculated as follows: (Width baseline − Width 48h )/Width baseline .
Flow cytometric analysis
Cells were harvested, washed with PBS and fixed overnight in 4% formaldehyde at −20°C. Then, the cell was stained with propidium iodide using 
Results
AOC4P is upregulated in GC cell lines and tumor tissues
To investigate the expression levels of AOC4P in GC, we performed qRT-PCR in two GC cell lines (MGC-803 and BGC-823) and a human gastric epithelial cell line (GES-1). Consistent with our previous study, as shown in Figure  1 (a), AOC4P was highly expressed in GC cell lines compared with the gastric epithelial cell line. Next, we determined the relative expression of AOC4P in 63 paired GC tumor tissues and corresponding adjacent noncancerous tissues. The expression levels of AOC4P were also significantly higher in tumor tissues than in noncancerous tissues, suggesting involvement of AOC4P in the tumorigenesis of GC [ Figure  1 (Table 1) , a critical step for tumor dissemination. As shown in Table 2 , univariate and multivariate Cox regression analysis has revealed that AOC4P expression was strongly associated with disease-free survival and overall survival. These findings suggest that AOC4P is associated with metastasis and can serve as a prognostic biomarker.
Knockdown of AOC4P inhibits cellular proliferation and colony formation in vitro
To investigate the biological effects of AOC4P on cellular growth and colony formation, lossof-function experiments were conducted. We first Meanwhile, western blot assay showed that the expression of apoptosis-related proteins, including cleaved caspase-3 and cleaved PARP, were significantly increased after knockdown of AOC4P [ Figure 3(b) ]. Collectively, these data indicate that knockdown of AOC4P inhibits GC cells proliferation and promotes apoptosis.
Effect of AOC4P on migration and invasion of GC cells
We used Transwell and wound healing assays to determine the effect of AOC4P on migration and invasion of GC cells. As shown in Figure 4 (a) and (b), the migration and invasion abilities of GC cells were significantly decreased when AOC4P expression was reduced in MGC-803 and BGC-823 cells. These results suggested that AOC4P promotes the migration and invasion of GC cells.
Knockdown of AOC4P inhibits GC tumorigenesis in vivo
To explore whether AOC4P affects tumorigenesis in vivo, BGC-823 cells were stably transfected with si-AOC4P or the empty vector and then injected subcutaneously into the left and right flanks of each mouse, respectively. At 14 days after injection, tumors formed in the si-AOC4P group were significantly smaller than those in the si-NC group [ Figure 5 
AOC4P modulates GC tumorigenesis via epithelial-mesenchymal transition
A recent study reported that AOC4P suppresses hepatocellular carcinoma via inhibition of epithelial-mesenchymal transition (EMT). 15 Therefore, we investigated whether AOC4P functions in a similar manner in GC. After knockdown of AOC4P in BGC-823 and MGC-803 cells, qRT-PCR analysis revealed an increase in E-cadherin expression, while vimentin and MMP9 expression was reduced [ Figure 6 (a)]. Western blot assays confirmed these changes at the protein level [ Figure 6 (b)]. Interestingly, immunofluorescence results of cancer tissues showed that tumors with high expression AOC4P had relatively low levels of E-cadherin and high levels of vimentin and MMP9 (Figure 7) . Therefore, these results suggest that AOC4P modulates GC tumorigenesis by regulating EMT.
Discussion
GC is frequently diagnosed as locally advanced in
China, leading to the fact that patients in China have a poor estimated 5-year overall survival of 27.4% compared with 73.2% in Korea. 1, 16 One of the solutions to improve prognoses of patients with GC is early detection and intervention strategies. Therefore, we have focused on investigating novel diagnostic markers and potential therapeutic targets of GC. 11, 17, 18 Recently we identified five differentially expressed lncRNAs between tumor and adjacent normal tissues by lncRNA microarray profiling, including TINCR, CCAT2, AOC4P, BANCR, and LNC00857. 11 Using these circulating lncRNAs, we established a five-lncRNA panel for early detection of GC. In the present study, we investigated the role of tissular AOC4P in GC. We found significant upregulation of AOC4P in GC tissues, and that a high expression level of AOC4P was correlated with poor survival and lymphovascular invasion in patients with GC. Functionally, in vitro and in vivo assays demonstrated that AOC4P promoted tumor growth by inducing proliferation, migration, and invasion, and reducing apoptosis. Mechanistically, the oncogenic effect of AOC4P in GC might be partly attributed to AOC4P-mediated EMT. These data are helpful to explain the significance of AOC4P upregulation in GC and its correlation with clinicopathological characteristics.
Thus far, the functions of AOC4P have only been investigated in colon cancer and hepatocellular carcinoma. 15, 19 In colon cancer, AOC4P (also termed UPAT) is upregulated in highly tumorigenic colon cancer cells and involved in epigenetic regulation of cancer cells by modulating protein ubiquitination and degradation. 19 Similar to its functions in GC, Taniue and colleagues found that AOC4P plays a critical role in tumorigenicity of colon cancer cells. 19 However, in hepatocellular carcinoma, the expression of AOC4P was downregulated in 68% of tumor tissues. 15 Our results, together with earlier findings, indicated varied expression of AOC4P in different types of carcinomas.
A previous study has also reported different expression levels of lncRNA BANCR in GC and colon cancer. 20, 21 The fact that AOC4P is expressed differentially in various carcinomas might be partly explained by its various functions. In this study, we found that inhibition of AOC4P increased the expression of E-cadherin, while reducing the expression of vimentin and MMP9. Consistent with these findings, immunofluorescence of tumor specimens confirmed the correlation of AOC4P expression with E-cadherin, vimentin, and MMP9 levels. Therefore, AOC4P might exert its oncogenic effect in GC via EMT processes.
As a central driver of tumor malignancy, EMT is involved in cancer cell dissemination, drug resistance, subsequent disease recurrence, and acquisition of immunosuppressive capabilities in a variety of cancers. 22 It has been proposed that essentially all carcinomas develop malignancyassociated characteristics via activation of an EMT process in their constituent neoplastic cells. 22 One of the hallmarks of EMT is replacement of E-cadherin by N-cadherin, which results in the formation of far weaker cell-cell adhesions between adjacent cells. Importantly, a study from the Asian Cancer Research Group has classified GC into four molecular subtypes, among which the EMT type has the worst prognosis, the tendency to occur at an earlier age, and the highest recurrence frequency. 5 Therefore, as a regulator of EMT, AOC4P might be a potential therapeutic target for GC treatment.
Our earlier findings demonstrated a correlation between circulating AOC4P and tissular AOC4P. 11 Circulating lncRNAs in blood are usually incorporated into exosomes, which are small vesicles of endocytic origin that carry a variety of bioactive molecules, including proteins, lipids, RNA, and DNA. 23 Metastasis is a multistep process including invasion of tumor cells into local tissues at a primary tumor site, invasion into blood and lymph vessels, survival in circulation, extravasation from circulation to distant sites, and adaptation and proliferation in the metastatic site. Evidence has shown the involvement of exosomes in all processes of metastasis. 24 Currently, we have only demonstrated that AOC4P promoted tumorigenesis and cancer progression intracellularly. Therefore, our future study will focus on how tissular AOC4P incorporates into exosomes and is released into circulation, and the role of AOC4P-incorporated exosomes in metastatic sites.
Several limitations of present study should be taken into consideration when interpreting the results. First, the prognostic role of AOC4P needed to be validated in another independent cohort. Second, we did not unveil the downstream molecules which AOC4P regulated, therefore the molecular pathway through which AOC4P exerts its function needed a further indepth investigation.
Conclusion
Taken together, our results revealed a relationship between AOC4P and clinicopathological characteristics and demonstrated the prognostic potential of AOC4P for GC. We also revealed the involvement of AOC4P in proliferation, migration, invasion, and apoptosis of MGC-803 and BGC-823 cells. Our study indicates that AOC4P promotes tumorigenesis and progression partly through EMT.
